Your browser doesn't support javascript.
loading
A targeted genetic association study of epithelial ovarian cancer susceptibility.
Earp, Madalene; Winham, Stacey J; Larson, Nicholas; Permuth, Jennifer B; Sicotte, Hugues; Chien, Jeremy; Anton-Culver, Hoda; Bandera, Elisa V; Berchuck, Andrew; Cook, Linda S; Cramer, Daniel; Doherty, Jennifer A; Goodman, Marc T; Levine, Douglas A; Monteiro, Alvaro N A; Ness, Roberta B; Pearce, Celeste L; Rossing, Mary Anne; Tworoger, Shelley S; Wentzensen, Nicolas; Bisogna, Maria; Brinton, Louise; Brooks-Wilson, Angela; Carney, Michael E; Cunningham, Julie M; Edwards, Robert P; Fogarty, Zachary C; Iversen, Edwin S; Kraft, Peter; Larson, Melissa C; Le, Nhu D; Lin, Hui-Yi; Lissowska, Jolanta; Modugno, Francesmary; Moysich, Kirsten B; Olson, Sara H; Pike, Malcolm C; Poole, Elizabeth M; Rider, David N; Terry, Kathryn L; Thompson, Pamela J; van den Berg, David; Vierkant, Robert A; Vitonis, Allison F; Wilkens, Lynne R; Wu, Anna H; Yang, Hannah P; Ziogas, Argyrios; Phelan, Catherine M; Schildkraut, Joellen M.
Afiliação
  • Earp M; Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA.
  • Winham SJ; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
  • Larson N; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
  • Permuth JB; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Sicotte H; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
  • Chien J; Department of Cancer Biology, University of Kansas Cancer Center, Kansas City, KS, USA.
  • Anton-Culver H; Department of Epidemiology, University of California Irvine, Irvine, CA, USA.
  • Bandera EV; Rutgers Cancer Institute of New Jersey and Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
  • Berchuck A; Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA.
  • Cook LS; Division of Epidemiology and Biostatistics, University of New Mexico, Albuquerque, NM, USA.
  • Cramer D; Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Doherty JA; Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA.
  • Goodman MT; Section of Biostatistics and Epidemiology, The Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
  • Levine DA; Samuel Oschin Comprehensive Cancer Institute, Cedars Sinai Medical Center, Los Angeles, CA, USA.
  • Monteiro AN; Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Ness RB; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Pearce CL; The University of Texas School of Public Health, Houston, TX, USA.
  • Rossing MA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Tworoger SS; Department of Epidemiology, University of Washington, Seattle, WA, USA.
  • Wentzensen N; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Bisogna M; Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA.
  • Brinton L; Channing Division of Network Medicine, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.
  • Brooks-Wilson A; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Carney ME; Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Cunningham JM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Edwards RP; Genome Sciences Centre, BC Cancer Agency, Vancouver, BC, Canada.
  • Fogarty ZC; Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, BC, Canada.
  • Iversen ES; Clinical and Translational Research Program, University of Hawaii Cancer Center, Honolulu, HI, USA.
  • Kraft P; Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Mayo Clinic, Rochester, MN, USA.
  • Larson MC; Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Gynecologic Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Le ND; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
  • Lin HY; Department of Statistical Science, Duke University, Durham, NC, USA.
  • Lissowska J; Departments of Epidemiology and Biostatistics, Harvard School of Public Health, Boston, MA, USA.
  • Modugno F; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
  • Moysich KB; Cancer Control Research, BC Cancer Agency, Vancouver, BC, Canada.
  • Olson SH; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Pike MC; Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center & Institute of Oncology, Warsaw, Poland.
  • Poole EM; Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Gynecologic Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Rider DN; Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA.
  • Terry KL; Cancer Research Program, Magee-Women's Research Institute and University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.
  • Thompson PJ; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, US.
  • van den Berg D; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Vierkant RA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Vitonis AF; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, US.
  • Wilkens LR; Channing Division of Network Medicine, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.
  • Wu AH; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
  • Yang HP; Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Ziogas A; Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA.
  • Phelan CM; Samuel Oschin Comprehensive Cancer Institute, Cedars Sinai Medical Center, Los Angeles, CA, USA.
  • Schildkraut JM; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Oncotarget ; 7(7): 7381-9, 2016 Feb 16.
Article em En | MEDLINE | ID: mdl-26848776

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Biomarcadores Tumorais / Neoplasias Epiteliais e Glandulares / Predisposição Genética para Doença / Polimorfismo de Nucleotídeo Único / Estudos de Associação Genética Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Oncotarget Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Biomarcadores Tumorais / Neoplasias Epiteliais e Glandulares / Predisposição Genética para Doença / Polimorfismo de Nucleotídeo Único / Estudos de Associação Genética Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Oncotarget Ano de publicação: 2016 Tipo de documento: Article